Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

Tudor Investment Corporation »

Celldex Therapeutics shares owned by Tudor Investment Corporation

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Tudor Investment Corporation from 13F filings

Historical chart of Tudor Investment Corporation investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Tudor Investment Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download consolidated filings csv

Download as Excel

Download consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Tudor Investment Corporation

Quarter filed	Position value	Share count	Share price at filing
2023-12-31	$577k	15k	39.66
2023-09-30	$607k	22k	27.52
2023-06-30	$803k	24k	33.93
2023-03-31	$981k	27k	35.97

More positions owned by Tudor Investment Corporation

Ishares Russell 2000 Etf - US ETP ETF Option Call Option (IWM)

Splunk Inc - US Equity

Pioneer Natural Resources Co - US Equity (PXD)

Financial Select Sector Spdr Fund - US ETP ETF Option Call Option (XLF)

Ishares Msci Emerging Markets Etf - US ETP ETF Option Call Option (EEM)

Spdr Dow Jones Industrial Average Etf Trust - US E ETF Option Call Option (DIA)

Exxon Mobil Corp - US Equity (XOM)

Meta Platforms Inc - US Equity (META)

Bristol-Myers Squibb Co - US Equity (BMY)

Texas Instruments Inc - US Equity Option Call Option (TXN)

Enphase Energy Inc - US Equity Option Call Option (ENPH)

United Parcel Service Inc - US Class B Equity Option Call Option (UPS)

Nvidia Corp - US Equity (NVDA)

Bank Of America Corp - US Equity (BAC)

Estee Lauder Cos Inc/The - US Equity (EL)

View all positions for Tudor Investment Corporation

Top funds holding Celldex Therapeutics

Wellington Management Company

Eventide Asset Management

Kynam Capital Management

Point72 Asset Management

Octagon Capital Advisors

Commodore Capital

Jennison Associates

Charles Schwab Investment Management

5AM Venture Management

Goldman Sachs Group

Sphera Funds Management

View all funds holding Celldex Therapeutics

© 2024 stockzoa - Track 13F-HR Filings for Hedge Funds and Value Investors.

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z